Corporate Tech Investors

Alkermes

Alkermes is a corporate VC investing group that partners with companies that are a good strategic fit.

Venture Investor Overview

Contact Information

Background Information

Overview

Alkermes (NASDAQ: ALKS) is a leader in innovative medicines that address the unmet needs and challenges of people living with debilitating diseases. As a fully integrated global biopharmaceutical company, Alkermes applies our scientific expertise, proprietary technologies, and global resources to develop products that are designed to make a meaningful difference in the way patients manage their disease.

Profile

Social Media

Company News

Facebook

YouTube

Last Transaction

8/25/2014

Transaction History

Our records indicate that Alkermes invested in the VC transactions listed below. Dollar amounts are for the entire raise, which may include other investors.

Investor Contacts

Title

Name

Email & Social

Chief Executive Officer

Richard Pops

        

Funds

No fund closings have been recorded for this company.

Portfolio Companies

Alkermes has invested in only one tech company, according to our database records. If we are missing a portfolio company, please let us know.

Browse more corporate investors:

Alira Health | All Canadian Self-Storage

Share this article

About Our Corporate Tech Investor Database

The strategic investor data above is provided by VentureDeal.com, a leading provider of corporate tech investing transaction data.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary